Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Xlrl Inhibitors

Xlrl inhibitors are chemical compounds specifically designed to target and inhibit the Xlrl protein, a member of a protein family involved in key regulatory processes within cells. Although Xlrl is not fully characterized, it is believed to play a role in gene expression regulation, intracellular signaling, and possibly cellular structural maintenance. Proteins like Xlrl are typically associated with binding to nucleic acids or interacting with other regulatory proteins, thus influencing transcriptional processes and contributing to the control of various cellular functions. Xlrl may also be involved in modulating cellular responses to environmental stimuli, acting as a mediator in pathways that regulate the flow of information between the cell's internal and external environments.

Inhibitors of Xlrl function by binding to specific active or regulatory sites on the protein, preventing it from executing its biological role in these pathways. By blocking Xlrl's activity, these inhibitors can interfere with cellular processes such as gene expression, protein synthesis, or intracellular communication. This disruption may have downstream effects on a variety of cellular mechanisms, including the regulation of cell growth, differentiation, and stress responses. Understanding the structural and functional properties of Xlrl inhibitors, including their precise interaction sites and the changes they induce in Xlrl, is critical for exploring how these compounds modulate protein function at a molecular level. Such insights provide valuable information on how Xlrl's inhibition impacts broader cellular processes, particularly those dependent on precise regulatory control of gene expression and signaling networks.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D inhibits gene expression by preventing RNA polymerase activity necessary for transcription.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide inhibits RNA polymerase activity, leading to decreased transcription and potentially impacting expression of the RIKEN cDNA 3830403N18 gene.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin inhibits bacterial RNA polymerase and potentially could impact RNA polymerase activity involved in transcription of the RIKEN cDNA 3830403N18 gene.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin specifically inhibits RNA polymerase II, which is crucial for mRNA transcription, potentially affecting the expression of the RIKEN cDNA 3830403N18 gene.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Mycophenolic acid inhibits inosine monophosphate dehydrogenase, disrupting guanine nucleotide synthesis and potentially impacting gene expression, including the RIKEN cDNA 3830403N18 gene.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$142.00
$558.00
4
(1)

Ellipticine intercalates into DNA, leading to inhibition of RNA and DNA synthesis, potentially impacting the expression of the RIKEN cDNA 3830403N18 gene.

Triamterene

396-01-0sc-213103A
sc-213103
1 g
5 g
$22.00
$53.00
(0)

Triamterene has been shown to inhibit RNA synthesis, potentially affecting the expression of the RIKEN cDNA 3830403N18 gene.

Aclacinomycin A

57576-44-0sc-200160
5 mg
$129.00
10
(1)

Aclarubicin intercalates into DNA and inhibits topoisomerase II, potentially impacting DNA replication and transcription of the RIKEN cDNA 3830403N18 gene.